ASTRAZENECA PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 45.0%

Wed, 11 Aug

ASTRAZENECA PHARMA has announced its results for the quarter ended June 2021. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Jun-20*	3 Mar-21*	3 Jun-21*	QoQ Change	YoY Change
Net Sales	Rs m	1,936	2,103	1,754	-16.6%	-9.4%
Other income	Rs m	26	26	29	13.6%	9.5%
Turnover	Rs m	1,962	2,128	1,783	-16.2%	-9.1%
Expenses	Rs m	1,650	1,698	1,598	-5.9%	-3.2%
Gross profit	Rs m	286	404	156	-61.3%	-45.3%
Depreciation	Rs m	46	58	48	-18.5%	4.4%
Interest	Rs m	3	3	3	-5.7%	-2.9%
Profit before tax	Rs m	264	368	135	-63.3%	-48.8%
Tax	Rs m	78	96	33	-65.9%	-57.9%
Profit after tax	Rs m	186	273	102	-62.5%	-45.0%
Gross profit margin	%	14.8	19.2	8.9
Effective tax rate	%	29.4	26.0	24.2
Net profit margin	%	9.5	12.8	5.7

Year-on-Year Performance:

• The company's operating income during the quarter fell 9.4% on a year-on-year (YoY) basis. The expenses were down by 3.2% YoY during the same period.
• The company's operating profit declined by 45.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 8.9% in 1QFY22 as against 14.8% in 1QFY21.
• Depreciation charges increased by 4.4% and finance costs declined by 2.9% YoY, respectively.
• Other income increased by 9.5% YoY during the quarter.
• Net profit for the quarter declined by 45.0% YoY. Net profit margins during the quarter declined from 9.5% in 1QFY21 to 5.7% in 1QFY22.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter fell 16.6% on a quarter-on-quarter (QoQ) basis. The expenses were down by 5.9% QoQ during the same period.
• The company's operating profit declined by 61.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 8.9% in 1QFY22 as against 19.2% in 4QFY21.
• Net profit for the quarter declined by 62.5% QoQ, while net profit margins declined from 12.8% in 4QFY21 to 5.7% in 1QFY22.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved down from Rs 3,332.5 to Rs 3,203.4, registering a Loss of Rs 129.1 or around 3.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 25,998.4 (down 1.4%). Over the last one year it has moved up from 19,379.8 to 25,998.4, a gain of 6,619 points (up 34.2%).

Overall, the S&P BSE SENSEX is up 42.6% over the year.

Current Valuations

At the current price of Rs 3,203.4, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 94.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 17.6 times.